Your browser doesn't support javascript.
loading
The identification of novel immunogenic antigens as potential Shigella vaccine components.
de Alwis, Ruklanthi; Liang, Li; Taghavian, Omid; Werner, Emma; The, Hao Chung; Thu, Trang Nguyen Hoang; Duong, Vu Thuy; Davies, D Huw; Felgner, Philip L; Baker, Stephen.
Afiliación
  • de Alwis R; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.
  • Liang L; Viral Research and Experimental Medicine Centre, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore.
  • Taghavian O; Vaccine Research & Development Center, School of Medicine, University of California Irvine, Irvine, CA, USA.
  • Werner E; Vaccine Research & Development Center, School of Medicine, University of California Irvine, Irvine, CA, USA.
  • The HC; Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge, UK.
  • Thu TNH; The Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
  • Duong VT; The Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
  • Davies DH; The Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
  • Felgner PL; Vaccine Research & Development Center, School of Medicine, University of California Irvine, Irvine, CA, USA.
  • Baker S; Vaccine Research & Development Center, School of Medicine, University of California Irvine, Irvine, CA, USA.
Genome Med ; 13(1): 8, 2021 01 15.
Article en En | MEDLINE | ID: mdl-33451348

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas contra la Shigella / Antígenos Bacterianos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Genome Med Año: 2021 Tipo del documento: Article País de afiliación: Singapur

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas contra la Shigella / Antígenos Bacterianos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Genome Med Año: 2021 Tipo del documento: Article País de afiliación: Singapur